Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bicycle Therapeutics (BCYC) Total Non-Current Liabilities: 2018-2025

Historic Total Non-Current Liabilities for Bicycle Therapeutics (BCYC) over the last 7 years, with Sep 2025 value amounting to $144.4 million.

  • Bicycle Therapeutics' Total Non-Current Liabilities fell 9.62% to $144.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $144.4 million, marking a year-over-year decrease of 9.62%. This contributed to the annual value of $162.7 million for FY2024, which is 26.00% down from last year.
  • Per Bicycle Therapeutics' latest filing, its Total Non-Current Liabilities stood at $144.4 million for Q3 2025, which was down 10.95% from $162.1 million recorded in Q2 2025.
  • Over the past 5 years, Bicycle Therapeutics' Total Non-Current Liabilities peaked at $229.7 million during Q2 2023, and registered a low of $78.9 million during Q1 2021.
  • In the last 3 years, Bicycle Therapeutics' Total Non-Current Liabilities had a median value of $178.8 million in 2024 and averaged $180.6 million.
  • Its Total Non-Current Liabilities has fluctuated over the past 5 years, first spiked by 106.49% in 2021, then declined by 26.84% in 2024.
  • Over the past 5 years, Bicycle Therapeutics' Total Non-Current Liabilities (Quarterly) stood at $130.3 million in 2021, then increased by 4.41% to $136.0 million in 2022, then surged by 61.65% to $219.8 million in 2023, then declined by 26.00% to $162.7 million in 2024, then fell by 9.62% to $144.4 million in 2025.
  • Its Total Non-Current Liabilities was $144.4 million in Q3 2025, compared to $162.1 million in Q2 2025 and $142.4 million in Q1 2025.